In the United Kingdom, 30 cases of thrombosis have been identified following the use of AstraZeneca vaccine up to 24 March, 25 reported more than mid-March. This is what the healthcare regulator writes in a new report on Thursday. Similar reports would not have been made after injecting the BioNTech/Pfizer vaccine.
The UK Medicines Authority reports about a ‘very small’ risk of the rare combination of blood clots and reduced platelet counts due to the AstraZeneca vaccine. There are 30 cases out of a total of 18.1 million shots in the United Kingdom. The benefits of vaccination against Covid-19 continue to outweigh the possible risks, according to the regulator. The same conclusion is drawn by the European Medicines Agency this week, which has also found no evidence of a causal relationship between the AstraZeneca vaccine and the health problems involved.
Meanwhile, in Australia, a thrombosis case following an AstraZeneca injection is “taken very seriously”, the authorities reported in Australian media on Friday. The case concerns a 44-year-old male who was found to have thrombosis and low platelet counts after an injection with AstraZeneca vaccine. The researchers of the Ministry of Health have not yet been able to find a causal connection between the vaccine and the complications involved. The majority of 670,000 Australians who have been vaccinated so far received with AstraZeneca vaccine.